APA (7th ed.) Citation

MS, L., L, Z., L, W., S, B., JS, H., UM, L., . . . HR, S. (2023). IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer. Frontiers in immunology, 14, 1163136. https://doi.org/10.3389/fimmu.2023.1163136

Chicago Style (17th ed.) Citation

MS, Lutz, Zekri L, Weßling L, Berchtold S, Heitmann JS, Lauer UM, Jung G, and Salih HR. "IgG-based B7-H3xCD3 Bispecific Antibody for Treatment of Pancreatic, Hepatic and Gastric Cancer." Frontiers in Immunology 14 (2023): 1163136. https://doi.org/10.3389/fimmu.2023.1163136.

MLA (9th ed.) Citation

MS, Lutz, et al. "IgG-based B7-H3xCD3 Bispecific Antibody for Treatment of Pancreatic, Hepatic and Gastric Cancer." Frontiers in Immunology, vol. 14, 2023, p. 1163136, https://doi.org/10.3389/fimmu.2023.1163136.